Peptides Market Report

Europe Peptides Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 13, 2020
  • PAGES：137
  • REPORT CODE：GMM434323
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Peptides market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Peptides Market Segmentations:

    By Player:

    • Gland Pharma Limited

    • VHB Life Sciences Limited

    • Biological E Limited

    • Bharat Biotech

    • United Biotech (P) Limited

    By Type:

    • Insulin

    • Teriparatide

    • Liraglutide

    • Leuprolide

    By End-User:

    • Diabetes

    • Infectious Diseases

    • Cancer

    • Osteoporosis

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptides Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Peptides Market Size and Growth Rate of Insulin from 2014 to 2026

    • 1.3.2 Europe Peptides Market Size and Growth Rate of Teriparatide from 2014 to 2026

    • 1.3.3 Europe Peptides Market Size and Growth Rate of Liraglutide from 2014 to 2026

    • 1.3.4 Europe Peptides Market Size and Growth Rate of Leuprolide from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Peptides Market Size and Growth Rate of Diabetes from 2014 to 2026

    • 1.4.2 Europe Peptides Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • 1.4.3 Europe Peptides Market Size and Growth Rate of Cancer from 2014 to 2026

    • 1.4.4 Europe Peptides Market Size and Growth Rate of Osteoporosis from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Peptides Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Peptides Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Peptides Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Peptides by Major Types

      • 3.4.1 Market Size and Growth Rate of Insulin

      • 3.4.2 Market Size and Growth Rate of Teriparatide

      • 3.4.3 Market Size and Growth Rate of Liraglutide

      • 3.4.4 Market Size and Growth Rate of Leuprolide

    4 Segmentation of Peptides Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Peptides by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Peptides for Diabetes

      • 4.4.2 Market Size and Growth Rate of Peptides for Infectious Diseases

      • 4.4.3 Market Size and Growth Rate of Peptides for Cancer

      • 4.4.4 Market Size and Growth Rate of Peptides for Osteoporosis

    5 Market Analysis by Major Regions

    • 5.1 Europe Peptides Production Analysis by Top Regions

    • 5.2 Europe Peptides Consumption Analysis by Top Regions

    • 5.3 Europe Peptides Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Peptides Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Peptides Production, Import, Consumption and Export Analysis

      • 5.3.3 France Peptides Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Peptides Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Peptides Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Peptides Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Peptides Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Peptides Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Peptides Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Peptides Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Peptides Production, Import, Consumption and Export Analysis

    6 Product Circulation of Peptides Market among Top Countries

    • 6.1 Top 5 Export Countries in Peptides Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Peptides Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Peptides Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Peptides Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Peptides Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Peptides Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Peptides Landscape Analysis

    • 7.1 Germany Peptides Landscape Analysis by Major Types

    • 7.2 Germany Peptides Landscape Analysis by Major End-Users

    8. UK Peptides Landscape Analysis

    • 8.1 UK Peptides Landscape Analysis by Major Types

    • 8.2 UK Peptides Landscape Analysis by Major End-Users

    9. France Peptides Landscape Analysis

    • 9.1 France Peptides Landscape Analysis by Major Types

    • 9.2 France Peptides Landscape Analysis by Major End-Users

    10. Italy Peptides Landscape Analysis

    • 10.1 Italy Peptides Landscape Analysis by Major Types

    • 10.2 Italy Peptides Landscape Analysis by Major End-Users

    11. Spain Peptides Landscape Analysis

    • 11.1 Spain Peptides Landscape Analysis by Major Types

    • 11.2 Spain Peptides Landscape Analysis by Major End-Users

    12. Poland Peptides Landscape Analysis

    • 12.1 Poland Peptides Landscape Analysis by Major Types

    • 12.2 Poland Peptides Landscape Analysis by Major End-Users

    13. Russia Peptides Landscape Analysis

    • 13.1 Russia Peptides Landscape Analysis by Major Types

    • 13.2 Russia Peptides Landscape Analysis by Major End-Users

    14. Switzerland Peptides Landscape Analysis

    • 14.1 Switzerland Peptides Landscape Analysis by Major Types

    • 14.2 Switzerland Peptides Landscape Analysis by Major End-Users

    15. Turkey Peptides Landscape Analysis

    • 15.1 Turkey Peptides Landscape Analysis by Major Types

    • 15.2 Turkey Peptides Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Landscape Analysis by Top Countries

      • 16.3.1 Denmark Peptides Market Volume and Growth Rate

      • 16.3.2 Finland Peptides Market Volume and Growth Rate

      • 16.3.3 Norway Peptides Market Volume and Growth Rate

      • 16.3.4 Sweden Peptides Market Volume and Growth Rate

      • 16.3.6 Iceland Peptides Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Peptides Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Peptides Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Peptides Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Peptides Landscape Analysis by Top Countries

      • 17.3.1 Belgium Peptides Market Volume and Growth Rate

      • 17.3.2 Netherlands Peptides Market Volume and Growth Rate

      • 17.3.3 Luxembourg Peptides Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Peptides Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Peptides Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Peptides Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Peptides Landscape Analysis by Top Countries

      • 18.3.1 Estonia Peptides Market Volume and Growth Rate

      • 18.3.2 Latvia Peptides Market Volume and Growth Rate

      • 18.3.3 Lithuania Peptides Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Gland Pharma Limited

      • 19.1.1 Gland Pharma Limited Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 VHB Life Sciences Limited

      • 19.2.1 VHB Life Sciences Limited Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Biological E Limited

      • 19.3.1 Biological E Limited Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Bharat Biotech

      • 19.4.1 Bharat Biotech Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 United Biotech (P) Limited

      • 19.5.1 United Biotech (P) Limited Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    The List of Tables and Figures (Totals 88 Figures and 121 Tables)

    • Figure Product Picture

    • Figure Europe Peptides Market Size and Growth Rate of Insulin from 2014 to 2026

    • Figure Europe Peptides Market Size and Growth Rate of Teriparatide from 2014 to 2026

    • Figure Europe Peptides Market Size and Growth Rate of Liraglutide from 2014 to 2026

    • Figure Europe Peptides Market Size and Growth Rate of Leuprolide from 2014 to 2026

    • Figure Europe Peptides Market Size and Growth Rate of Diabetes from 2014 to 2026

    • Figure Europe Peptides Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • Figure Europe Peptides Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Europe Peptides Market Size and Growth Rate of Osteoporosis from 2014 to 2026

    • Figure Germany Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure UK Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure France Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Peptides Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Peptides

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Peptides by Different Types from 2014 to 2026

    • Table Consumption Share of Peptides by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Insulin

    • Figure Market Size and Growth Rate of Teriparatide

    • Figure Market Size and Growth Rate of Liraglutide

    • Figure Market Size and Growth Rate of Leuprolide

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Peptides by Different End-Users from 2014 to 2026

    • Table Consumption Share of Peptides by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Osteoporosis

    • Table Europe Peptides Production by Major Regions

    • Table Europe Peptides Production Share by Major Regions

    • Figure Europe Peptides Production Share by Major Countries and Regions in 2014

    • Table Europe Peptides Consumption by Major Regions

    • Table Europe Peptides Consumption Share by Major Regions

    • Table Germany Peptides Production, Import, Consumption and Export Analysis

    • Table UK Peptides Production, Import, Consumption and Export Analysis

    • Table France Peptides Production, Import, Consumption and Export Analysis

    • Table Italy Peptides Production, Import, Consumption and Export Analysis

    • Table Spain Peptides Production, Import, Consumption and Export Analysis

    • Table Poland Peptides Production, Import, Consumption and Export Analysis

    • Table Russia Peptides Production, Import, Consumption and Export Analysis

    • Table Switzerland Peptides Production, Import, Consumption and Export Analysis

    • Table Turkey Peptides Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptides Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptides Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Peptides Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Peptides Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Peptides Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Peptides Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Peptides Consumption by Types from 2014 to 2026

    • Table Germany Peptides Consumption Share by Types from 2014 to 2026

    • Table Germany Peptides Consumption by End-Users from 2014 to 2026

    • Table Germany Peptides Consumption Share by End-Users from 2014 to 2026

    • Table UK Peptides Consumption by Types from 2014 to 2026

    • Table UK Peptides Consumption Share by Types from 2014 to 2026

    • Table UK Peptides Consumption by End-Users from 2014 to 2026

    • Table UK Peptides Consumption Share by End-Users from 2014 to 2026

    • Table France Peptides Consumption by Types from 2014 to 2026

    • Table France Peptides Consumption Share by Types from 2014 to 2026

    • Table France Peptides Consumption by End-Users from 2014 to 2026

    • Table France Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Italy Peptides Consumption by Types from 2014 to 2026

    • Table Italy Peptides Consumption Share by Types from 2014 to 2026

    • Table Italy Peptides Consumption by End-Users from 2014 to 2026

    • Table Italy Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Spain Peptides Consumption by Types from 2014 to 2026

    • Table Spain Peptides Consumption Share by Types from 2014 to 2026

    • Table Spain Peptides Consumption by End-Users from 2014 to 2026

    • Table Spain Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Poland Peptides Consumption by Types from 2014 to 2026

    • Table Poland Peptides Consumption Share by Types from 2014 to 2026

    • Table Poland Peptides Consumption by End-Users from 2014 to 2026

    • Table Poland Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Russia Peptides Consumption by Types from 2014 to 2026

    • Table Russia Peptides Consumption Share by Types from 2014 to 2026

    • Table Russia Peptides Consumption by End-Users from 2014 to 2026

    • Table Russia Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Peptides Consumption by Types from 2014 to 2026

    • Table Switzerland Peptides Consumption Share by Types from 2014 to 2026

    • Table Switzerland Peptides Consumption by End-Users from 2014 to 2026

    • Table Switzerland Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Peptides Consumption by Types from 2014 to 2026

    • Table Turkey Peptides Consumption Share by Types from 2014 to 2026

    • Table Turkey Peptides Consumption by End-Users from 2014 to 2026

    • Table Turkey Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptides Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Peptides Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptides Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptides Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptides Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptides Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptides Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peptides Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptides Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptides Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptides Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptides Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptides Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Peptides Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Gland Pharma Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gland Pharma Limited

    • Figure Sales and Growth Rate Analysis of Gland Pharma Limited

    • Figure Revenue and Market Share Analysis of Gland Pharma Limited

    • Table Product and Service Introduction of Gland Pharma Limited

    • Table Company Profile and Development Status of VHB Life Sciences Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of VHB Life Sciences Limited

    • Figure Sales and Growth Rate Analysis of VHB Life Sciences Limited

    • Figure Revenue and Market Share Analysis of VHB Life Sciences Limited

    • Table Product and Service Introduction of VHB Life Sciences Limited

    • Table Company Profile and Development Status of Biological E Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biological E Limited

    • Figure Sales and Growth Rate Analysis of Biological E Limited

    • Figure Revenue and Market Share Analysis of Biological E Limited

    • Table Product and Service Introduction of Biological E Limited

    • Table Company Profile and Development Status of Bharat Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech

    • Figure Sales and Growth Rate Analysis of Bharat Biotech

    • Figure Revenue and Market Share Analysis of Bharat Biotech

    • Table Product and Service Introduction of Bharat Biotech

    • Table Company Profile and Development Status of United Biotech (P) Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of United Biotech (P) Limited

    • Figure Sales and Growth Rate Analysis of United Biotech (P) Limited

    • Figure Revenue and Market Share Analysis of United Biotech (P) Limited

    • Table Product and Service Introduction of United Biotech (P) Limited

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US